Introduction
The complicated interaction between the immune inflammatory response and periodontopathogenic bacteria usually results in chronic periodontitis (CP).
In clinical terms, CP is characterized by periodontal pockets, gingival inflammation, and loss of attachment to and in the alveolar bone, which can eventually lead to tooth loss. 1 Pathogenic mechanisms of the disease may involve antioxidant (AO) activity and oxygen-dependent ROS production. A study conducted by Chapple, et al. 4 (1997) correlated PD with reduced salivary AO status, and increased oxidative damage in the oral cavity. Other studies have examined a possible relation between PD, reduced salivary AO status, and increased oxidative damage. 5, 6 An increase in levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of oxidative stress, has also been reported to be associated with periodontitis. 7 Treatments for periodontitis focus on reducing pathogens embedded in the subgingival biofilm. 8 Modalities range from oral hygiene instruction, 
Materials and methods

Study population
We utilized a randomized, parallel controlled, and 
Clinical examination
One month after the second ozone application, plaque index (PI), 23 gingival index (GI), 24 probing depth, and CAL were recorded for each patient.
A manual periodontal probe (PCP-12, Hu-Friedy, Chicago, IL, USA) was used for all clinical parameter measurements.
Saliva collection and laboratory assessments
Saliva samples from all patients were taken via expectoration before treatment and one month after the second treatment application (ozone or placebo).
Paraffin wax-stimulated, whole saliva samples were After treatment, changes in the PI, GI, probing depth, and CAL were also similar for both groups (p>0.05) ( Table 2 ).
Baseline laboratory findings were similar for both groups (p>0.05). The increase of MPO and TAS was observed in both groups after treatment (p<0.05).
However, the increase of TGF-β levels was significantly greater in the test group compared with controls (p<0.05). Levels of 8-OHdG decreased in both groups after treatment (p<0.05) ( Table 3) .
Changes in 8-OHdG, GSH, MDA, MPO, TAS, TOS,
and NO levels were similar between groups (p>0.05).
Statistically significant differences between the ozone and control groups were limited to TGF-β levels following treatment (p<0.05) ( Table 3) .
Discussion
This is the first study to evaluate both clinical and biochemical in vivo effects of gaseous ozone on oxidative stress (TAS and TOS) and TGF-β, a marker for periodontal recovery. Ozone was applied in addition to noninvasive periodontal treatment. Levels of MDA, a lipid peroxidation end product; GSH, an AO molecule; 8-OHdG, a marker of purin oxidation product; and NO, an oxidant agent were assessed. Results showed that the application of gaseous ozone was not associated with significant changes in periodontal recovery. of attachment loss, the decrease in pocket depth, and the elimination of inflammation. 25 In order to reach these goals, the first treatment option for patients whose pockets are not deep is non-surgical. 26 However, the success of non-surgical treatment with hand tools and cavitron is limited where pockets are difficult to reach. 10 In addition, the effectiveness of non-surgical treatment in tissue regeneration, a primary therapeutic target, is less than ideal. As such, changing the host Oxidant and AO molecules are also known to play important roles in the immune response to PD.
Primary goals for the treatment of PD are the recycling
immune
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For this purpose, we evaluated the effects of ozone treatment on oxidants and AOs by assaying levels of TOS, NO, 8-OHdG, MDA, GSH, and TAS in saliva to investigate the ozone effects on the immune response in PD. According to our findings, although increase in AO levels and decrease in oxidant levels were more pronounced in the ozone-treated group, no statistically significant differences were observed for any specific clinical parameters. These findings suggest that the stimulatory effects of ozone administration on periodontal tissues may be limited.
In addition, TGF-β levels were evaluated as a biochemical marker for tissue recovery. Previous studies have reported that an increase in TGF-β levels was associated with a decrease in periodontal inflammation, leading to improved outcomes. 40 We did observe that TGF-β levels increased significantly in the ozone-treated group, supporting the claim that gaseous ozone treatment increases the regeneration activity of periodontal tissues. The difference in TGF-β levels could indicate that ozone therapy can contribute to periodontal treatment; however, we found that clinical recovery and changes to biochemical parameters were similar for both groups, confounding this result. The ozone application effect on whole oxidant and AO levels may be limited due to multiple factors involved in immune response and recovery.
Follow-up was limited to one month after second treatment application, which did not permit the evaluation of long-term periodontal outcomes.
Although this period was beneficial in terms of eliminating the differences in hygiene practices among the patients and evaluating the short-term host responses, further studies on the long-term effects of ozone treatment on PD are needed. 
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